WCLC 2025 - Posters & ePosters-P2.10.15 Mechanistic Study of Osimertinib Combined With Sitravatinibto Overcome Acquired Osimertinib Resistance in Non-Small Cell Lung Cancer

P2.10.15 Mechanistic Study of Osimertinib Combined With Sitravatinibto Overcome Acquired Osimertinib Resistance in Non-Small Cell Lung Cancer

Asset Subtitle

Xiangqin Wang

Meta Tag

Speaker Xiangqin Wang

Topic Metastatic Non-small Cell Lung Cancer – Cytotoxic Therapy